BNBX — BNB PLUS CORP.

Nasdaq · Unknown · Unknown · CIK 744452 ·
Last close
$0.40
Market Cap
$2.88M
52W High
$0.85
52W Low
$0.37
ADV30
1,707,244
Next earnings
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,024,111 826,786 -2,137,010 -6,665,227 13,634,864 949,091 1,504,931
Dec 2025 565,394 315,357 -13,491,715 -18,593,563 20,697,042 2,450,536 2,236,894
Sep 2025 199,429 -167,980 -5,996,949 -5,271,774 4,437,441 1,667,800 2,495,748
Jun 2025 304,393 5,130 -3,694,060 -3,945,363 9,934,746 4,727,677 2,946,702

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-14,449,066
Investing CF
$-3,189,743
Financing CF
$11,063,630
CapEx
$-684,371
Dividends Paid
Buybacks
EPS Diluted TTM
$-683.86
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-397,786,765
Inventory
$89,954
Receivables
$546,739
ST Investments
EBIT TTM
$-26,644,519
Pretax Income TTM
$-31,645,024
Interest Exp TTM
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,832,038
EBITDA
$-28,339,856
Free Cash Flow
$-17,404,216
Enterprise Value
$-380,461
Total Cash
$2,450,536
Total Debt
$48,861
Shares Out
7,197,228
Trailing EPS
$373.62
Book Value
$1.39
ROE
-199.1%
ROA
-98.0%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Sep 2025 2,136,935 -16,046,595 -15,160,724 4,437,441 2,495,748 -12,518,695
Sep 2024 2,113,490 -13,668,447 -6,992,521 12,789,040 3,820,955 -13,711,410
Sep 2023 13,367,443 -10,953,290 -9,947,059 13,651,577 8,779,165 -6,217,677
Sep 2022 18,168,677 -13,969,763 -8,267,891 22,265,114 9,356,175 -8,976,706

News headlines (Yahoo Finance, 1h cache)

BNB Plus Adds $4.1M as Crypto Treasury Reset Moves Forward
2026-05-26 14:14 · Yahoo
OBOOK Holdings (OWLS) and BNB Plus Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2026-02-06 17:35 · Yahoo
BNB Plus Corp.: Bet on Binance Ecosystem with Best-in-Class Yield – Exec Edge Initiation Report
2026-01-28 15:01 · Yahoo
RedChip Highlights High-Growth Opportunities in Fintech and Digital Asset Treasury Strategies at February 4 Virtual Conference
2026-01-28 13:00 · Yahoo
BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th
2026-01-27 13:00 · Yahoo
BNB Plus acquires 3,349 additional BNB tokens for approximately $3M
2025-12-10 14:40 · Yahoo
Inside the Crypto Stock Frenzy: How a $58 Million BNB Bet Sent Applied DNA Into Chaos
2025-10-16 18:37 · Yahoo
Applied DNA Sciences Becomes a B2i Digital Featured Company to Share Its Strategic Rebrand and BNB-Focused Treasury Shift With Investors
2025-10-15 12:30 · Yahoo
Applied DNA Reports Private Placement to Start BNB Treasury
2025-09-29 20:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.